Skip to main content
. Author manuscript; available in PMC: 2017 Dec 5.
Published in final edited form as: Cell Rep. 2017 Oct 3;21(1):195–207. doi: 10.1016/j.celrep.2017.09.021

Figure 6. ICOShiCCR6+RORγt+ Treg cells are Ag-specific regulatory T cells with potent suppressive activity in vitro.

Figure 6

(A) ICOShiCCR6+GFPCD4+ Th17 cells were isolated seven days after MOG/CFA s.c. immunization of CD45.2+Foxp3GFP reporter mice. In parallel, ICOShiCCR6+GFP+CD4+ Treg cells, ICOSloCCR6GFP+CD4+ Treg cells, and ICOShiCCR6GFP+CD4+ Treg cells were isolated from MOG/CFA immunized CD45.1+CD45.2+ Foxp3GFP reporter mice. Th17 cells were stimulated with MOG peptide (50 μg/ml) in the presence of irradiated T cell-depleted splenocytes (TdS, CD45.1+). Three fold serially diluted number of each Treg cells were added to the culture to test the suppressive activity. Three days later, IL-17A, IL-17F or IL-22 production in the culture supernatant was analyzed by ELISA. (B) Foxp3GFP reporter mice were s.c. immunized with MOG/CFA. Seven days later, MOG-specific cells in indicated populations of dLNs were identified by tetramer staining. (C) ICOShiGFPCD4+CD45.1+ T effector cells (Teff) were labeled with CFSE (2.0 μM) and then were stimulated with splenic CD11c+ DCs in the presence or absence of ICOShiCCR6+GFP+CD4+CD45.2+ Tr17 cells in the indicated Tr17 to Teff ratio. Three days later, FSC value, CFSE dilution, CD25 expression and cytokine production of CD45.1+ Teff cells were analyzed by flow cytometry after PMA/Ionomycin restimulation. Data are representatives of at least two independent experiments. *, p<0.05. **, p<0.005. See also Figure S4.